Invizius
Pharmaceutical Manufacturing
Bo'ness Road, United Kingdom
12 employees
- Employees
- 12
- Contacts
- 1
- Emails
- 1
Invizius Overview
- Headquarters
- Bo'ness Road, United Kingdom
- Website
- invizius.com
- Industry
- Pharmaceutical Manufacturing
- Employees
- 12
- Founded
- 2018
- Funding
- 1.3M
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation Manufacturing
About Invizius
Invizius is a spin-out based on world-class Complement research carried out at the University of Edinburgh, Scotland. Complement is 1.3b years old and part of the innate immune system. As it is the most ancient part of the immune system it is involved at the beginning of every inflammatory response. We fight inflammation at its source. Invizius is developing Second Generation Complement Therapeutics to significantly improve the clinical outcomes of patients with dysregulated complement systems leading to inflammation and fibrosis. Our first indication for H-Guard is in Acute Kidney Injury receiving CRRT where there is filter membrane associated Complement driven damage to renal tubule cells as well as local and systemic inflammatory damage. Our second product Meso-Guard is for patients on Renal replacement Therapy receiving Peritoneal Dialysis. This product should extend the PD treatment window by reducing fibrotic changes caused by peritoneal dialysis fluid. Despite significant improvements in haemodialysis membranes Complement activation by contact with a foreign surface remains a serious issue with short, medium and long term clinical implications. Other acute application of H-Guard is for coating Cardiopulmonary Bypass and ECMO filters. Other applications of our platform include IgA Nephropathy, Preeclampsia, SLE and Neuroinflammation.
Invizius Contact Details
- People in AeroLeads
- 4
- With contact data
- 1
- Email contacts
- 1
- 25.0% coverage
Invizius Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Joanna Anderson | Quality Assurance Manager at Ingenza |
View
|
|
| Maria Moffat | Finance Manager |
View
|
|
| Dr Magnus Nicolson | Chief Executive Officer @ Invizius - Developing Complement Therapeutics | Balfron, Scotland, United Kingdom |
Email
|
| Dr. Sandra Neumann | Senior Vice President, Global Operations, Ferring Pharmaceuticals Experienced Executive with Broad Experience in Pharma, Medtech and Commercial | Zurich, Switzerland |
View
|
Employees by Management Level
Executive
2 profiles
Manager
2 profiles
Individual contributor
2 profiles
Department Contact Coverage
| Department | Contacts | Phone | |
|---|---|---|---|
| General | 1 | 1 | 0 |
Invizius Tech Stack
Data / AI
2 profiles
Compare Similar Companies to Invizius
PACT
Textile Manufacturing
Macomics
Biotechnology Research
Vicebio
Biotechnology Research
NeoPhore Ltd
Biotechnology Research
LIfT BioSciences
Biotechnology Research
Fermtech
Biotechnology
ILC Therapeutics
Pharmaceutical Manufacturing
Corryn Biotechnologies
Medical Equipment Manufacturing
Kynos Therapeutics
Biotechnology
Caldan Therapeutics
Biotechnology Research